Customer Center
Login | Register

LUMINEX PATENTS

Luminex Virtual Patent Marking

 

The following Luminex products are protected by patents in the United States and elsewhere. This web page is provided to satisfy the virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of Section 16 of the America Invents Act. The following list of products and patents may not be all inclusive. For example, some products listed here may be covered by patents in the United States and elsewhere that are not listed, and other products not listed here may be protected by one or more patents in the United States and elsewhere. The products may be sold individually or as a part of a combination product, kit, or system, and the listed patents would apply in both cases. Additional patents may be pending in the United States or elsewhere.

 

Luminex, MAGPIX, FLEXMAP 3D, ARIES, xPONENT, MicroPlex, LumAvidin, xTAG, MultiCode, xMAP, and NxTAG are trademarks of Luminex Corporation, registered in the U.S. and other countries. SeroMAP, Luminex 100, Luminex 200, and MagPlex-TAG are trademarks of Luminex Corporation. MultiFLEX is a trademark of GenArraytion, Inc.

Instruments

 

MAGPIX®

This product, or use thereof, is covered in whole or in part by US Patent Nos. 8,031,918, 8,296,088, 8,274,656, 8,532,351, 8,542,897, 8,798,951, 8,859,996, 8,889,347, 9,063,088, 9,286,504, and 9,292,938; Australian Patent Nos. 2010253487, 2011280055, and 2014250695; European (UK) Patent Nos. EP1929274 and EP2769198; Hong Kong Patent No. HK1166128; and foreign counterparts thereof.

 

Luminex® 100™

This product, or use thereof, is covered in whole or in part by US Patent Nos. 6,411,904, 6,658,357 and 7,047,138; Australian Patent No. 2010202161; European (UK) Patent Nos. EP0852004 and EP1754965; Hong Kong Patent No. HK1148587; and foreign counterparts thereof.

 

Luminex® 200™

This product, or use thereof, is covered in whole or in part by US Patent Nos. 6,411,904, 6,658,357 and 7,047,138; Australian Patent No. 2010202161; European (UK) Patent Nos. EP0852004 and EP1754965; Hong Kong Patent No. HK1148587; and foreign counterparts thereof.

 

FLEXMAP 3D®

This product, or use thereof, is covered in whole or in part by US Patent Nos. 6,411,904, 6,658,357, 7,047,138, 7,318,336, 7,523,637, and 9,273,344; Australian Patent Nos. 2010202161 and 2010202162; European (UK) Patent Nos. EP0852004 and EP1754965; Hong Kong Patent Nos. HK1148587 and HK1148586; and foreign counterparts thereof.

 

ARIES® System

This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,754,148, 7,910,062, 8,029,746, 8,168,443, 8,476,078, 8,900,877, and 9,074,250; Australian Patent Nos. 2012216238 and 2014224115; and foreign counterparts thereof.

 

ARIES® M1 System

This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,754,148, 7,910,062, 8,029,746, 8,168,443, 8,476,078, 8,900,877, and 9,074,250; Australian Patent Nos. 2012216238 and 2014224115; and foreign counterparts thereof.

 

xPONENT® versions 3.0 and 3.1

This product, or use thereof, is covered in whole or in part by US Patent No. 7,523,637; and Australian Patent No. 2010202161; and foreign counterparts thereof.

 

xPONENT® version 4.2

This product, or use thereof, is covered in whole or in part by US Patent No. 8,859,996, and foreign counterparts thereof.

 

Verigene® Processor SP

This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,695,952 and 7,888,107.

 

Back to Top

Reagents

 

MicroPlex® Microspheres

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

LumAvidin® Microspheres

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

SeroMAP™ Microspheres

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

MagPlex® Microspheres

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

xTAG® Microspheres

This product, or the use or manufacture thereof, is covered, in whole or in part, by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,645,868, and US 8,624,014; European (UK) Patent No. EP 1364065, Australian Patent Nos. 2002227829 and 2008201349; and foreign counterparts thereof.

 

MagPlex-TAG™ Microspheres

This product, or the use or manufacture thereof, is covered, in whole or in part, by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 7,645,868, US 8,624,014, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

MAGPIX® Calibration Kit

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

MAGPIX® Performance Verification Kit

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

Luminex® 100/200™ Calibration Kit

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

Luminex® 100/200™ Performance Verification Kit

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

FLEXMAP 3D® Calibration Kit

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

FLEXMAP 3D® Performance Verification Kit

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

MultiCode® ISOlution

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,820,808 and 8,313,932; and Australian Patent No. 2004227353; and foreign counterparts thereof. The use of this product may be covered by one or more of US Patent Nos. 7,422,850 and 7,541,147; Australian Patent No. 2001271254; European (UK) Patent Nos. EP1349954 and EP1615942; Hong Kong Patent No. 1061410; and foreign counterparts thereof.

 

Back to Top

Assays

 

xTAG® Gastrointestinal Pathogen Panel (xTAG GPP)

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, and 8,968,874; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

The purchase of this product grants the purchaser the rights under certain Roche patents to use it solely for providing human in vitro diagnostic services. No general patent or other license of any kind other than this specific right of use from purchase is granted hereby.

 

xTAG® Cystic Fibrosis Assays (xTAG® Cystic Fibrosis 39 kit v2, xTAG® Cystic Fibrosis 60 kit v2, xTAG® Cystic Fibrosis 71 kit v2)

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,645,868, and US 8,624,014; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent No. EP 1364065; and foreign counterparts thereof.

Luminex Molecular Diagnostics, Inc. has licensed the rights to sell products for the analysis of genetic variants in the CFTR genes from the Hospital for Sick Children (Toronto) and the University of Michigan. The purchaser of this kit is granted the right to use the contents of this kit to perform analyses of these genetic variants, and to sell the results of this analysis if desired. No rights or licenses are granted to the purchaser of this kit to perform these analyses other than through the direct use of the contents of this kit.

 

xTAG® Respiratory Viral Panel (RVP) v1

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,645,868, and US 8,624,014; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent No. EP 1364065; and foreign counterparts thereof.

The purchase of this product grants the purchaser the rights under certain Roche patents to use it solely for providing human in vitro diagnostic services. No general patent or other license of any kind other than this specific right of use from purchase is granted hereby.

 

xTAG® Respiratory Viral Panel (RVP) FAST

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US Patent Nos. 6,514,295, 6,599,331, 6,632,526, 6,929,859, 7,645,868, 8,624,014, and 9,376,613; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent No. EP 1364065; and foreign counterparts thereof.

The purchase of this product grants the purchaser the rights under certain Roche patents to use it solely for providing human in vitro diagnostic services. No general patent or other license of any kind other than this specific right of use from purchase is granted hereby.

 

xTAG® Respiratory Viral Panel (RVP) FAST v2

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, 8,283,037, 8,568,881, 8,968,874, US 7,645,868, and US 8,624,014; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1364065, EP 1842211, and EP 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

The purchase of this product grants the purchaser the rights under certain Roche patents to use it solely for providing human in vitro diagnostic services. No general patent or other license of any kind other than this specific right of use from purchase is granted hereby.

 

xTAG® Cerebrospinal Fluid Pathogens (CSF) Viral Panel

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, and 8,968,874; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

xTAG® Cerebrospinal Fluid Pathogens (CSF) Bacterial Panel

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, and 8,968,874; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

xTAG® Blood Pathogen Panel (BPP)

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US Patent Nos. 6,514,295, 6,599,331, 6,632,526, 6,929,859, 7,718,262, 7,645,868, 8,624,014, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

xTAG® CYP2D6 Kit v3 (xTAG® P450-2D6 Kit v3)

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,645,868, and US 8,624,014; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent No. EP 1364065; and foreign counterparts thereof.

 

xTAG® CYP2C19 Kit v3 (xTAG® P450-2C19 Kit v3)

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

Luminex Molecular Diagnostics, Inc. has licensed the rights to sell products for nucleic acid analysis under U.S. Patent No. 5,912,120, including related applications and foreign counterparts thereof. The purchaser of this kit is granted rights under this license to use the contents of this kit to perform nucleic acid analyses and to sell the results of this analysis if desired. No other rights or licenses are granted to the purchaser of this kit to perform any other analyses or acts other than those permitted under this provision.

 

MultiCode®-RTx HSV 1&2 Kit

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,517,651, 7,541,147, and 8,519,117; Australian Patent No. 2001271254; European (UK) Patent No. EP1349954; Hong Kong Patent No. 1061410; and foreign counterparts thereof.

 

xMAP® Salmonella Serotyping Assay (xMAP SSA)

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, and US 6,929,859, and foreign counterparts thereof.

 

xMAP® Biothreat Toxin Panel

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; Australian Patent No. 2011280967; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

xMAP® MultiFLEX™ BioAssays

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

xMAP® MultiFLEX™ Zika RNA Assay

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

ARIES® GBS Assay

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,517,651, 7,541,147, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,519,117, 8,900,877, 9,017,617, and 9,074,250; Australian Patent Nos. 2001271254, 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1349954; Hong Kong Patent No. 1061410; and foreign counterparts thereof.

 

ARIES® Flu A/B & RSV Assay

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,517,651, 7,541,147, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,519,117, 8,900,877, 9,017,617, and 9,074,250; Australian Patent Nos. 2001271254, 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1349954; Hong Kong Patent No. 1061410; and foreign counterparts thereof.

 

ARIES® HSV 1&2

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,517,651, 7,541,147, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,519,117, 8,900,877, 9,017,617, and 9,074,250; Australian Patent Nos. 2001271254, 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1349954; Hong Kong Patent No. 1061410; and foreign counterparts thereof.

 

ARIES® Extraction Cassette

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,517,651, 7,541,147, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,519,117, 8,900,877, 9,017,617, and 9,074,250; Australian Patent Nos. 2001271254, 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1349954; Hong Kong Patent No. 1061410; and foreign counterparts thereof.

 

NxTAG® Respiratory Pathogen Panel

This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 6,514,295, US 6,599,331, US 6,632,526, US 6,929,859, US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.

 

Verigene® Gram-Positive Blood Culture (BC-GP) Test

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 6,750,016, 6,602,669, 6,361,944, 6,506,564, 6,759,199, 6,645,721, 6,673,548, 6,903,207, 6,818,753, 6,986,989, 6,720,147, 8,323,888, 7,250,499, and 7,321,829.

 

Verigene® Gram-Negative Blood Culture (BC-GN) Test

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 6,750,016, 6,602,669, 6,361,944, 6,506,564, 6,759,199, 6,645,721, 6,673,548, 6,903,207, 6,818,753, 6,986,989, 6,720,147, 8,323,888, 7,250,499, and 7,321,829.

 

Verigene® Respiratory Pathogens Flex™ (RP Flex) Test

This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 6,750,016, 6,602,669, 6,361,944, 6,506,564, 6,759,199, 6,645,721, 6,673,548, 6,903,207, 6,818,753, 6,986,989, 6,720,147, 8,323,888, 7,250,499, and 7,321,829.

 

Back to Top

Accessories

 

Magnetic Plate Separator

This product, or use thereof, is covered in whole or in part by US Patent No. 8,747,677.

 

Back to Top